The non-receptor tyrosine kinase Src and receptor tyrosine kinase epidermal growth factor receptor (EGFR/ErbB1) have been established as collaborators in cellular signaling and their combined dysregulation plays key roles in human cancers, including breast cancer. In part due to the complexity of the biochemical network associated with the regulation of these proteins as well as their cellular functions, the role of Src in EGFR regulation remains unclear. Herein we present a new comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cells. This model, constructed manually from published biochemical literature, consists of 245 nodes representing proteins and their post-translational modifi...
AbstractThe human epidermal growth factor receptor (HER/ErbB) system comprises the epidermal growth ...
Summarization: The importance of ErbB receptor signaling in breast cancer is consistent with its fun...
AbstractBreast cancer cells develop resistance to endocrine therapies by shifting between estrogen r...
The non-receptor tyrosine kinase Src and receptor tyrosine kinase epidermal growth factor receptor (...
The non-receptor tyrosine kinase Src and receptor tyrosine kinase epidermal growth factor receptor (...
Transactivation of the epidermal growth factor receptor (EGFR) is thought to be a process by which a...
Src and EGFR are co-overexρressed or co-overactivated in ~ 70 % of breast cancers. This suggests tha...
Deregulation of ErbB signaling plays a key role in the progression of multiple human cancers. To hel...
The EGFR/Erb-B receptor tyrosine kinases each play distinct and complementary roles in normal breast...
Src, a non-receptor tyrosine kinase, is a key signal transduction partner of epidermal growth factor...
It is well established that epidermal growth factor (EGF) is a potent mitogen in cells expressing EG...
It is well established that epidermal growth factor (EGF) is a potent mitogen in cells expressing EG...
Abstract Background Knowledge about signaling pathways is typically compiled based on data gathered ...
Deregulation of ErbB signaling plays a key role in the progression of multiple human cancers. To hel...
AbstractTo study the relationship between the tyrosine kinase c-Src and the epidermal growth factor ...
AbstractThe human epidermal growth factor receptor (HER/ErbB) system comprises the epidermal growth ...
Summarization: The importance of ErbB receptor signaling in breast cancer is consistent with its fun...
AbstractBreast cancer cells develop resistance to endocrine therapies by shifting between estrogen r...
The non-receptor tyrosine kinase Src and receptor tyrosine kinase epidermal growth factor receptor (...
The non-receptor tyrosine kinase Src and receptor tyrosine kinase epidermal growth factor receptor (...
Transactivation of the epidermal growth factor receptor (EGFR) is thought to be a process by which a...
Src and EGFR are co-overexρressed or co-overactivated in ~ 70 % of breast cancers. This suggests tha...
Deregulation of ErbB signaling plays a key role in the progression of multiple human cancers. To hel...
The EGFR/Erb-B receptor tyrosine kinases each play distinct and complementary roles in normal breast...
Src, a non-receptor tyrosine kinase, is a key signal transduction partner of epidermal growth factor...
It is well established that epidermal growth factor (EGF) is a potent mitogen in cells expressing EG...
It is well established that epidermal growth factor (EGF) is a potent mitogen in cells expressing EG...
Abstract Background Knowledge about signaling pathways is typically compiled based on data gathered ...
Deregulation of ErbB signaling plays a key role in the progression of multiple human cancers. To hel...
AbstractTo study the relationship between the tyrosine kinase c-Src and the epidermal growth factor ...
AbstractThe human epidermal growth factor receptor (HER/ErbB) system comprises the epidermal growth ...
Summarization: The importance of ErbB receptor signaling in breast cancer is consistent with its fun...
AbstractBreast cancer cells develop resistance to endocrine therapies by shifting between estrogen r...